Biological effects of growth hormone and its antagonist.
Serum levels of growth hormone (GH) can vary. Low levels of GH can result in a dwarf phenotype and have been positively correlated with an increased life expectancy. High levels of GH can lead to gigantism or a clinical syndrome termed acromegaly and has been implicated in diabetic eye and kidney damage. Additionally the GH/IGF-1 system has been postulated as a risk factor for several types of cancers. Thus both elevated and suppressed circulating levels of GH can have pronounced physiological effects. More than a decade ago the first drug of a new class, a GH antagonist, was discovered. This molecule is now being tested for its ability to combat the effects of high circulating levels of GH. Here, we discuss some of the detrimental actions of GH, and how a GH antagonist can be used to combat these effects.
Okada
S
S
Edison Biotechnology Institute, Molecular and Cellular Biology Program, and Dept of Biomedical Sciences, College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.
Kopchick
J J
JJ
D000375:Aging / Q000502:physiology; D000818:Animals; D001823:Body Composition / Q000502:physiology; D004392:Dwarfism / Q000378:metabolism; D013006:Growth Hormone / Q000037:antagonists & inhibitors* / Q000502:physiology*; D006801:Humans
D013006:Growth Hormone